Programmed death ligand-1 expression in non-small cell lung cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2013-11-11

AUTHORS

Vamsidhar Velcheti, Kurt A Schalper, Daniel E Carvajal, Valsamo K Anagnostou, Konstantinos N Syrigos, Mario Sznol, Roy S Herbst, Scott N Gettinger, Lieping Chen, David L Rimm

ABSTRACT

Recent strategies targeting the interaction of the programmed cell death ligand-1 (PD-L1, B7-H1, CD274) with its receptor, PD-1, resulted in promising activity in early phase clinical trials. In this study, we used various antibodies and in situ mRNA hybridization to measure PD-L1 in non-small cell lung cancer (NSCLC) using a quantitative fluorescence (QIF) approach to determine the frequency of expression and prognostic value in two independent populations. A control tissue microarray (TMA) was constructed using PD-L1-transfected cells, normal human placenta and known PD-L1-positive NSCLC cases. Only one of four antibodies against PD-L1 (5H1) validated for specificity on this TMA. In situ PD-L1 mRNA using the RNAscope method was similarly validated. Two cohorts of NSCLC cases in TMAs including 340 cases from hospitals in Greece and 204 cases from Yale University were assessed. Tumors showed PD-L1 protein expression in 36% (Greek) and 25% (Yale) of the cases. PD-L1 expression was significantly associated with tumor-infiltrating lymphocytes in both cohorts. Patients with PD-L1 (both protein and mRNA) expression above the detection threshold showed statistically significant better outcome in both series (log-rank P=0.036 and P=0.027). Multivariate analysis showed that PD-L1 expression was significantly associated with better outcome independent of histology. Measurement of PD-L1 requires specific conditions and some commercial antibodies show lack of specificity. Expression of PD-L1 protein or mRNA is associated with better outcome. Further studies are required to determine the value of this marker in prognosis and prediction of response to treatments targeting this pathway. More... »

PAGES

107-116

Journal

TITLE

Laboratory Investigation

ISSUE

1

VOLUME

94

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/labinvest.2013.130

DOI

http://dx.doi.org/10.1038/labinvest.2013.130

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1024707845

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24217091


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "B7-H1 Antigen", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Non-Small-Cell Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chi-Square Distribution", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Connecticut", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Greece", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunohistochemistry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocytes, Tumor-Infiltrating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Messenger", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reproducibility of Results", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tissue Array Analysis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Solid Tumor, Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA", 
          "id": "http://www.grid.ac/institutes/grid.239578.2", 
          "name": [
            "Solid Tumor, Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Velcheti", 
        "givenName": "Vamsidhar", 
        "id": "sg:person.01355036115.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355036115.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Yale School of Medicine, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Pathology, Yale School of Medicine, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schalper", 
        "givenName": "Kurt A", 
        "id": "sg:person.0702425124.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702425124.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Yale School of Medicine, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Pathology, Yale School of Medicine, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carvajal", 
        "givenName": "Daniel E", 
        "id": "sg:person.0750540324.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750540324.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Yale School of Medicine, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Medical Oncology, Yale School of Medicine, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Anagnostou", 
        "givenName": "Valsamo K", 
        "id": "sg:person.01336552123.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336552123.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medicine, Oncology Unit, University of Athens, Sotiria General Hospital, Athens, Greece", 
          "id": "http://www.grid.ac/institutes/grid.5216.0", 
          "name": [
            "Department of Medical Oncology, Yale School of Medicine, New Haven, CT, USA", 
            "Department of Medicine, Oncology Unit, University of Athens, Sotiria General Hospital, Athens, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Syrigos", 
        "givenName": "Konstantinos N", 
        "id": "sg:person.015363113164.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015363113164.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Yale School of Medicine, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Medical Oncology, Yale School of Medicine, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sznol", 
        "givenName": "Mario", 
        "id": "sg:person.0706626451.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706626451.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Yale School of Medicine, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Medical Oncology, Yale School of Medicine, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Herbst", 
        "givenName": "Roy S", 
        "id": "sg:person.01150737671.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150737671.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, Yale School of Medicine, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Medical Oncology, Yale School of Medicine, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gettinger", 
        "givenName": "Scott N", 
        "id": "sg:person.01215766413.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215766413.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Medical Oncology, Yale School of Medicine, New Haven, CT, USA", 
            "Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Lieping", 
        "id": "sg:person.016303325577.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016303325577.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Yale School of Medicine, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Pathology, Yale School of Medicine, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rimm", 
        "givenName": "David L", 
        "id": "sg:person.0754207153.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754207153.13"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s12032-010-9515-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050627417", 
          "https://doi.org/10.1007/s12032-010-9515-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm730", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043110107", 
          "https://doi.org/10.1038/nm730"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri1349", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039451108", 
          "https://doi.org/10.1038/nri1349"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm791", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030132345", 
          "https://doi.org/10.1038/nm791"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-11-11", 
    "datePublishedReg": "2013-11-11", 
    "description": "Recent strategies targeting the interaction of the programmed cell death ligand-1 (PD-L1, B7-H1, CD274) with its receptor, PD-1, resulted in promising activity in early phase clinical trials. In this study, we used various antibodies and in situ mRNA hybridization to measure PD-L1 in non-small cell lung cancer (NSCLC) using a quantitative fluorescence (QIF) approach to determine the frequency of expression and prognostic value in two independent populations. A control tissue microarray (TMA) was constructed using PD-L1-transfected cells, normal human placenta and known PD-L1-positive NSCLC cases. Only one of four antibodies against PD-L1 (5H1) validated for specificity on this TMA. In situ PD-L1 mRNA using the RNAscope method was similarly validated. Two cohorts of NSCLC cases in TMAs including 340 cases from hospitals in Greece and 204 cases from Yale University were assessed. Tumors showed PD-L1 protein expression in 36% (Greek) and 25% (Yale) of the cases. PD-L1 expression was significantly associated with tumor-infiltrating lymphocytes in both cohorts. Patients with PD-L1 (both protein and mRNA) expression above the detection threshold showed statistically significant better outcome in both series (log-rank P=0.036 and P=0.027). Multivariate analysis showed that PD-L1 expression was significantly associated with better outcome independent of histology. Measurement of PD-L1 requires specific conditions and some commercial antibodies show lack of specificity. Expression of PD-L1 protein or mRNA is associated with better outcome. Further studies are required to determine the value of this marker in prognosis and prediction of response to treatments targeting this pathway.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/labinvest.2013.130", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2440220", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1017964", 
        "issn": [
          "0023-6837", 
          "1530-0307"
        ], 
        "name": "Laboratory Investigation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "94"
      }
    ], 
    "keywords": [
      "non-small cell lung cancer", 
      "PD-L1 expression", 
      "cell lung cancer", 
      "PD-L1", 
      "tissue microarray", 
      "better outcomes", 
      "NSCLC cases", 
      "lung cancer", 
      "death ligand 1 (PD-L1) expression", 
      "cell death ligand 1", 
      "PD-L1 protein expression", 
      "early phase clinical trials", 
      "ligand 1 expression", 
      "tumor-infiltrating lymphocytes", 
      "death ligand 1", 
      "significant better outcome", 
      "PD-L1 mRNA", 
      "phase clinical trials", 
      "PD-L1 protein", 
      "normal human placenta", 
      "prediction of response", 
      "quantitative fluorescence approaches", 
      "frequency of expression", 
      "PD-1", 
      "prognostic value", 
      "clinical trials", 
      "multivariate analysis", 
      "lack of specificity", 
      "human placenta", 
      "protein expression", 
      "ligand 1", 
      "antibodies", 
      "Further studies", 
      "promising activity", 
      "cohort", 
      "outcomes", 
      "commercial antibodies", 
      "cancer", 
      "situ mRNA hybridization", 
      "independent populations", 
      "mRNA hybridization", 
      "RNAscope method", 
      "expression", 
      "mRNA", 
      "patients", 
      "prognosis", 
      "hospital", 
      "lymphocytes", 
      "cases", 
      "tumors", 
      "histology", 
      "specificity", 
      "placenta", 
      "trials", 
      "receptors", 
      "treatment", 
      "detection threshold", 
      "markers", 
      "study", 
      "recent strategies", 
      "cells", 
      "population", 
      "microarray", 
      "pathway", 
      "response", 
      "protein", 
      "activity", 
      "lack", 
      "specific conditions", 
      "hybridization", 
      "threshold", 
      "frequency", 
      "values", 
      "strategies", 
      "analysis", 
      "series", 
      "Yale University", 
      "University", 
      "conditions", 
      "method", 
      "measurements", 
      "interaction", 
      "approach", 
      "Greece", 
      "fluorescence approach", 
      "prediction"
    ], 
    "name": "Programmed death ligand-1 expression in non-small cell lung cancer", 
    "pagination": "107-116", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1024707845"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/labinvest.2013.130"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24217091"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/labinvest.2013.130", 
      "https://app.dimensions.ai/details/publication/pub.1024707845"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_604.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/labinvest.2013.130"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/labinvest.2013.130'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/labinvest.2013.130'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/labinvest.2013.130'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/labinvest.2013.130'


 

This table displays all metadata directly associated to this object as RDF triples.

319 TRIPLES      21 PREDICATES      135 URIs      123 LITERALS      27 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/labinvest.2013.130 schema:about N039a0e3056f94c8b9505aa724c78dee5
2 N080f92c90f0d42a09694efaab5a59428
3 N0ba7715c810f4581a3682df564937a42
4 N16e4cc72a1d74860a2cf7a609a6cb1b7
5 N1ab55988e3eb4b9cb8f913380473a626
6 N1dd96fe602564073b94b7b183e429c3f
7 N202dab536fda438c89fb76e900429b43
8 N4d06dff3a84b476da79011860770b97b
9 N5e4036a18b49428b817ce88514b7832b
10 N724b7e89864042a095ea99ea4966ce83
11 N75b32513341c449088c6a0c4082b74d1
12 Naacce297ccf9453ebb307872b1ce552a
13 Nabc5aa8770144cf6b89c055c2aba0dd0
14 Nb2c4b044d38a4896abde256282931056
15 Nc261b4b3b3874e5abd5c77e2ec742128
16 Ncd485fa7ca5d41988c41c52a02bb45fe
17 Nd8cbafd3b9ad4b8296a260258473273c
18 Ne3c95f6147f94828b5c3cc8d7924c306
19 Nea426694b1fb49559975ac8ce571b4fd
20 Neda694f461714f02b48da8082f10d24d
21 anzsrc-for:11
22 anzsrc-for:1112
23 schema:author N30a13c3697944cbeb9ab8dd67ca464ea
24 schema:citation sg:pub.10.1007/s12032-010-9515-2
25 sg:pub.10.1038/nm730
26 sg:pub.10.1038/nm791
27 sg:pub.10.1038/nri1349
28 schema:datePublished 2013-11-11
29 schema:datePublishedReg 2013-11-11
30 schema:description Recent strategies targeting the interaction of the programmed cell death ligand-1 (PD-L1, B7-H1, CD274) with its receptor, PD-1, resulted in promising activity in early phase clinical trials. In this study, we used various antibodies and in situ mRNA hybridization to measure PD-L1 in non-small cell lung cancer (NSCLC) using a quantitative fluorescence (QIF) approach to determine the frequency of expression and prognostic value in two independent populations. A control tissue microarray (TMA) was constructed using PD-L1-transfected cells, normal human placenta and known PD-L1-positive NSCLC cases. Only one of four antibodies against PD-L1 (5H1) validated for specificity on this TMA. In situ PD-L1 mRNA using the RNAscope method was similarly validated. Two cohorts of NSCLC cases in TMAs including 340 cases from hospitals in Greece and 204 cases from Yale University were assessed. Tumors showed PD-L1 protein expression in 36% (Greek) and 25% (Yale) of the cases. PD-L1 expression was significantly associated with tumor-infiltrating lymphocytes in both cohorts. Patients with PD-L1 (both protein and mRNA) expression above the detection threshold showed statistically significant better outcome in both series (log-rank P=0.036 and P=0.027). Multivariate analysis showed that PD-L1 expression was significantly associated with better outcome independent of histology. Measurement of PD-L1 requires specific conditions and some commercial antibodies show lack of specificity. Expression of PD-L1 protein or mRNA is associated with better outcome. Further studies are required to determine the value of this marker in prognosis and prediction of response to treatments targeting this pathway.
31 schema:genre article
32 schema:isAccessibleForFree true
33 schema:isPartOf N12af7d5583204c539b8e0ea0340d6351
34 Na3c349cb62e645d78ba8558b83bbaf6e
35 sg:journal.1017964
36 schema:keywords Further studies
37 Greece
38 NSCLC cases
39 PD-1
40 PD-L1
41 PD-L1 expression
42 PD-L1 mRNA
43 PD-L1 protein
44 PD-L1 protein expression
45 RNAscope method
46 University
47 Yale University
48 activity
49 analysis
50 antibodies
51 approach
52 better outcomes
53 cancer
54 cases
55 cell death ligand 1
56 cell lung cancer
57 cells
58 clinical trials
59 cohort
60 commercial antibodies
61 conditions
62 death ligand 1
63 death ligand 1 (PD-L1) expression
64 detection threshold
65 early phase clinical trials
66 expression
67 fluorescence approach
68 frequency
69 frequency of expression
70 histology
71 hospital
72 human placenta
73 hybridization
74 independent populations
75 interaction
76 lack
77 lack of specificity
78 ligand 1
79 ligand 1 expression
80 lung cancer
81 lymphocytes
82 mRNA
83 mRNA hybridization
84 markers
85 measurements
86 method
87 microarray
88 multivariate analysis
89 non-small cell lung cancer
90 normal human placenta
91 outcomes
92 pathway
93 patients
94 phase clinical trials
95 placenta
96 population
97 prediction
98 prediction of response
99 prognosis
100 prognostic value
101 promising activity
102 protein
103 protein expression
104 quantitative fluorescence approaches
105 recent strategies
106 receptors
107 response
108 series
109 significant better outcome
110 situ mRNA hybridization
111 specific conditions
112 specificity
113 strategies
114 study
115 threshold
116 tissue microarray
117 treatment
118 trials
119 tumor-infiltrating lymphocytes
120 tumors
121 values
122 schema:name Programmed death ligand-1 expression in non-small cell lung cancer
123 schema:pagination 107-116
124 schema:productId N1ca0f97478c2417da972fb68cbbf0ba5
125 N6da54d3ba2d64dd8b810fe508359913e
126 N74ac1a85fcd543bd88f0ed80e542046b
127 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024707845
128 https://doi.org/10.1038/labinvest.2013.130
129 schema:sdDatePublished 2022-09-02T15:56
130 schema:sdLicense https://scigraph.springernature.com/explorer/license/
131 schema:sdPublisher N497116fe994f4dca9674ad65a75a8bf7
132 schema:url https://doi.org/10.1038/labinvest.2013.130
133 sgo:license sg:explorer/license/
134 sgo:sdDataset articles
135 rdf:type schema:ScholarlyArticle
136 N039a0e3056f94c8b9505aa724c78dee5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Aged
138 rdf:type schema:DefinedTerm
139 N080f92c90f0d42a09694efaab5a59428 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Greece
141 rdf:type schema:DefinedTerm
142 N0ba7715c810f4581a3682df564937a42 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Cell Line, Tumor
144 rdf:type schema:DefinedTerm
145 N12af7d5583204c539b8e0ea0340d6351 schema:volumeNumber 94
146 rdf:type schema:PublicationVolume
147 N16e4cc72a1d74860a2cf7a609a6cb1b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Lung Neoplasms
149 rdf:type schema:DefinedTerm
150 N1ab55988e3eb4b9cb8f913380473a626 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Chi-Square Distribution
152 rdf:type schema:DefinedTerm
153 N1ca0f97478c2417da972fb68cbbf0ba5 schema:name doi
154 schema:value 10.1038/labinvest.2013.130
155 rdf:type schema:PropertyValue
156 N1dd96fe602564073b94b7b183e429c3f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name B7-H1 Antigen
158 rdf:type schema:DefinedTerm
159 N202dab536fda438c89fb76e900429b43 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Immunohistochemistry
161 rdf:type schema:DefinedTerm
162 N30a13c3697944cbeb9ab8dd67ca464ea rdf:first sg:person.01355036115.98
163 rdf:rest Nfe3957a3cc724d05889253a367ab779b
164 N38bbf59a8741421f9cca49eb2f8d434a rdf:first sg:person.01215766413.87
165 rdf:rest Na7d649e1f0574ba58b215729256abd5a
166 N497116fe994f4dca9674ad65a75a8bf7 schema:name Springer Nature - SN SciGraph project
167 rdf:type schema:Organization
168 N4d06dff3a84b476da79011860770b97b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Connecticut
170 rdf:type schema:DefinedTerm
171 N5e4036a18b49428b817ce88514b7832b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Lymphocytes, Tumor-Infiltrating
173 rdf:type schema:DefinedTerm
174 N6da54d3ba2d64dd8b810fe508359913e schema:name dimensions_id
175 schema:value pub.1024707845
176 rdf:type schema:PropertyValue
177 N724b7e89864042a095ea99ea4966ce83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name RNA, Messenger
179 rdf:type schema:DefinedTerm
180 N74ac1a85fcd543bd88f0ed80e542046b schema:name pubmed_id
181 schema:value 24217091
182 rdf:type schema:PropertyValue
183 N75b32513341c449088c6a0c4082b74d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Carcinoma, Non-Small-Cell Lung
185 rdf:type schema:DefinedTerm
186 N8878dddc73c647f2b0021a0724d1c609 rdf:first sg:person.0754207153.13
187 rdf:rest rdf:nil
188 N8c36f8a22c564606bf1ab52cdfb5d02b rdf:first sg:person.0750540324.99
189 rdf:rest Nd70f4c5110784c268704f661b3c94c6e
190 Na3c349cb62e645d78ba8558b83bbaf6e schema:issueNumber 1
191 rdf:type schema:PublicationIssue
192 Na54da211f2214eee9e9802ef33589eda rdf:first sg:person.01150737671.46
193 rdf:rest N38bbf59a8741421f9cca49eb2f8d434a
194 Na7d649e1f0574ba58b215729256abd5a rdf:first sg:person.016303325577.21
195 rdf:rest N8878dddc73c647f2b0021a0724d1c609
196 Naacce297ccf9453ebb307872b1ce552a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Reproducibility of Results
198 rdf:type schema:DefinedTerm
199 Nabc5aa8770144cf6b89c055c2aba0dd0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Biomarkers, Tumor
201 rdf:type schema:DefinedTerm
202 Nb2c4b044d38a4896abde256282931056 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Survival Analysis
204 rdf:type schema:DefinedTerm
205 Nc261b4b3b3874e5abd5c77e2ec742128 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Cohort Studies
207 rdf:type schema:DefinedTerm
208 Nc382b8e308434bc383c53b3aa640cfb5 rdf:first sg:person.0706626451.72
209 rdf:rest Na54da211f2214eee9e9802ef33589eda
210 Ncd485fa7ca5d41988c41c52a02bb45fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Tissue Array Analysis
212 rdf:type schema:DefinedTerm
213 Nd70f4c5110784c268704f661b3c94c6e rdf:first sg:person.01336552123.46
214 rdf:rest Nd96e16df4ba943c3aa3cb05a81b6a2b6
215 Nd8cbafd3b9ad4b8296a260258473273c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
216 schema:name Female
217 rdf:type schema:DefinedTerm
218 Nd96e16df4ba943c3aa3cb05a81b6a2b6 rdf:first sg:person.015363113164.65
219 rdf:rest Nc382b8e308434bc383c53b3aa640cfb5
220 Ne3c95f6147f94828b5c3cc8d7924c306 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
221 schema:name Male
222 rdf:type schema:DefinedTerm
223 Nea426694b1fb49559975ac8ce571b4fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
224 schema:name Prognosis
225 rdf:type schema:DefinedTerm
226 Neda694f461714f02b48da8082f10d24d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
227 schema:name Humans
228 rdf:type schema:DefinedTerm
229 Nfe3957a3cc724d05889253a367ab779b rdf:first sg:person.0702425124.69
230 rdf:rest N8c36f8a22c564606bf1ab52cdfb5d02b
231 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
232 schema:name Medical and Health Sciences
233 rdf:type schema:DefinedTerm
234 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
235 schema:name Oncology and Carcinogenesis
236 rdf:type schema:DefinedTerm
237 sg:grant.2440220 http://pending.schema.org/fundedItem sg:pub.10.1038/labinvest.2013.130
238 rdf:type schema:MonetaryGrant
239 sg:journal.1017964 schema:issn 0023-6837
240 1530-0307
241 schema:name Laboratory Investigation
242 schema:publisher Springer Nature
243 rdf:type schema:Periodical
244 sg:person.01150737671.46 schema:affiliation grid-institutes:grid.47100.32
245 schema:familyName Herbst
246 schema:givenName Roy S
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150737671.46
248 rdf:type schema:Person
249 sg:person.01215766413.87 schema:affiliation grid-institutes:grid.47100.32
250 schema:familyName Gettinger
251 schema:givenName Scott N
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215766413.87
253 rdf:type schema:Person
254 sg:person.01336552123.46 schema:affiliation grid-institutes:grid.47100.32
255 schema:familyName Anagnostou
256 schema:givenName Valsamo K
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336552123.46
258 rdf:type schema:Person
259 sg:person.01355036115.98 schema:affiliation grid-institutes:grid.239578.2
260 schema:familyName Velcheti
261 schema:givenName Vamsidhar
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01355036115.98
263 rdf:type schema:Person
264 sg:person.015363113164.65 schema:affiliation grid-institutes:grid.5216.0
265 schema:familyName Syrigos
266 schema:givenName Konstantinos N
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015363113164.65
268 rdf:type schema:Person
269 sg:person.016303325577.21 schema:affiliation grid-institutes:grid.47100.32
270 schema:familyName Chen
271 schema:givenName Lieping
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016303325577.21
273 rdf:type schema:Person
274 sg:person.0702425124.69 schema:affiliation grid-institutes:grid.47100.32
275 schema:familyName Schalper
276 schema:givenName Kurt A
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702425124.69
278 rdf:type schema:Person
279 sg:person.0706626451.72 schema:affiliation grid-institutes:grid.47100.32
280 schema:familyName Sznol
281 schema:givenName Mario
282 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706626451.72
283 rdf:type schema:Person
284 sg:person.0750540324.99 schema:affiliation grid-institutes:grid.47100.32
285 schema:familyName Carvajal
286 schema:givenName Daniel E
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750540324.99
288 rdf:type schema:Person
289 sg:person.0754207153.13 schema:affiliation grid-institutes:grid.47100.32
290 schema:familyName Rimm
291 schema:givenName David L
292 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754207153.13
293 rdf:type schema:Person
294 sg:pub.10.1007/s12032-010-9515-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050627417
295 https://doi.org/10.1007/s12032-010-9515-2
296 rdf:type schema:CreativeWork
297 sg:pub.10.1038/nm730 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043110107
298 https://doi.org/10.1038/nm730
299 rdf:type schema:CreativeWork
300 sg:pub.10.1038/nm791 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030132345
301 https://doi.org/10.1038/nm791
302 rdf:type schema:CreativeWork
303 sg:pub.10.1038/nri1349 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039451108
304 https://doi.org/10.1038/nri1349
305 rdf:type schema:CreativeWork
306 grid-institutes:grid.239578.2 schema:alternateName Solid Tumor, Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
307 schema:name Solid Tumor, Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA
308 rdf:type schema:Organization
309 grid-institutes:grid.47100.32 schema:alternateName Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA
310 Department of Medical Oncology, Yale School of Medicine, New Haven, CT, USA
311 Department of Pathology, Yale School of Medicine, New Haven, CT, USA
312 schema:name Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA
313 Department of Medical Oncology, Yale School of Medicine, New Haven, CT, USA
314 Department of Pathology, Yale School of Medicine, New Haven, CT, USA
315 rdf:type schema:Organization
316 grid-institutes:grid.5216.0 schema:alternateName Department of Medicine, Oncology Unit, University of Athens, Sotiria General Hospital, Athens, Greece
317 schema:name Department of Medical Oncology, Yale School of Medicine, New Haven, CT, USA
318 Department of Medicine, Oncology Unit, University of Athens, Sotiria General Hospital, Athens, Greece
319 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...